Breaking News

Close

Catalyst Pharmaceuticals Inc (CPRX)

Add to/Remove from Watchlist Add to Watchlist

15.100 -0.030 -0.20%

- Closed. Currency in USD ( Disclaimer )

After Hours

15.010

-0.090

-0.596%

- Real-time Data

Type: Equity

Market: United States

Volume: 1,015,042
Bid/Ask: 15.000 / 15.520
Day's Range: 14.930 - 15.350

CPRX Balance Sheet

Featured here, the Balance Sheet for Catalyst Pharmaceuticals Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).

Annual Quarterly

InvestingPro

Advanced Balance Sheet

Period Ending:

2023

31/12

2023

30/09

2023

30/06

2023

31/03

Total Current Assets

219.33

192.02

240.97

198.91

Cash and Short Term Investments	137.64	120.97	178.79	148.25
Cash	-	-	-	-
Cash & Equivalents	137.64	120.97	178.79	148.25
Short Term Investments	-	-	-	-
Total Receivables, Net	53.65	48.2	42.98	33.62
Accounts Receivables - Trade, Net	53.65	48.2	42.98	33.62
Total Inventory	15.64	9.04	10.75	10.33
Prepaid Expenses	12.05	13.61	8.27	6.39
Other Current Assets, Total	0.351	0.206	0.182	0.335

Total Assets

470.11

413.21

443.9

407.23

Property/Plant/Equipment, Total - Net	3.7	3.76	3.84	3.99
Property/Plant/Equipment, Total - Gross	4.43	4.4	4.4	4.47
Accumulated Depreciation, Total	-0.723	-0.639	-0.557	-0.475
Goodwill, Net	-	-	-	-
Intangibles, Net	194.05	167.11	175.6	184.08
Long Term Investments	16.49	12.9	-	-
Note Receivable - Long Term	-	-	-	-
Other Long Term Assets, Total	-	-	-	-
Other Assets, Total	-1.11	-1.53	-8.55	-2.71

Total Current Liabilities

76.06

57.81

52.5

56.71

Accounts Payable	14.8	4.6	4.42	3.39
Payable/Accrued	-	-	-	-
Accrued Expenses	40.29	31.05	22.28	17.07
Notes Payable/Short Term Debt	-	-	-	-
Current Port. of LT Debt/Capital Leases	0.369	0.361	0.353	0.345
Other Current liabilities, Total	20.61	21.79	25.45	35.9

Total Liabilities

82.23

64.66

68.6

73.57

Total Long Term Debt	-	-	-	-
Long Term Debt	-	-	-	-
Capital Lease Obligations	-	-	-	-
Deferred Income Tax	-	-	-	-
Minority Interest	-	-	-	-
Other Liabilities, Total	6.17	6.86	16.1	16.86

Total Equity

387.88

348.55

375.29

333.66

Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-
Common Stock, Total	0.107	0.107	0.107	0.106
Additional Paid-In Capital	266.49	262	257.98	254.11
Retained Earnings (Accumulated Deficit)	121.27	86.43	117.19	79.43
Treasury Stock - Common	-	-	-	-
ESOP Debt Guarantee	-	-	-	-
Unrealized Gain (Loss)	-	-	-	-
Other Equity, Total	0.014	0.015	0.019	0.011

Total Liabilities & Shareholders' Equity

470.11

413.21

443.9

407.23

Total Common Shares Outstanding

107.12

106.61

106.5

105.94

Total Preferred Shares Outstanding

-

-

-

-

* In Millions of USD (except for per share items)

InvestingPro

Go to Dashboard InvestingPro

InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

CPRX Comments

Write your thoughts about Catalyst Pharmaceuticals Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Ishtiaq Bokhari Jan 11, 2024 10:48AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

the recent Morgan Stanley convention for the pharmaceutical in San Francisco CPR access proving to be liquidate company and is very well performing and it's way up and a good time to jump on the boat

3 0

Giuseppe Giannachi Jan 23, 2023 10:45AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Wow... what happened? Any news?

2 0

Timothy Murphy Sep 24, 2022 4:57PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

we need a rally boys!

2 0

jatin par Sep 15, 2022 1:53PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

why down today?

1 0

Timothy Murphy Aug 13, 2022 4:42PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

great investment, lets hope for even better profits, ahead!

1 0

Feb 02, 2021 11:59AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

This is the ultimate bull case no reckless gambling.. The best stock

9 0

Feb 02, 2021 11:58AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

The best stock with unlimited upside and practically no downside.

2 0

Feb 01, 2021 11:48AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Best Stock in industry healthy robust balance sheet plenty of cash and highly profitable! soo cheap

6 1

Imtanis Farah Jan 07, 2021 12:26PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

https://ir.catalystpharma.com/news-releases/news-release-details/catalyst-pharmaceuticals-announces-strategic-plan-product

0 0

Santosh Gujar Dec 22, 2020 12:07PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

next target 5.01

0 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="202177196">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="202177196" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="202177196" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="202177196">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	38,242.2	+2.2	+0.01%
	US 500	5,009.3	-1.3	-0.03%
	Dow Jones	38,239.98	+253.58	+0.67%
	S&P 500	5,010.60	+43.37	+0.87%
	Nasdaq	15,451.30	+169.29	+1.11%
	S&P 500 VIX	16.94	0.00	0.00%
	Dollar Index	106.040	+0.127	+0.12%

	Crude Oil WTI	82.11	+0.21	+0.26%
	Brent Oil	87.23	+0.23	+0.26%
	Natural Gas	2.059	-0.010	-0.48%
	Gold	2,320.10	-26.30	-1.12%
	Silver	26.975	-0.270	-0.99%
	Copper	4.4185	-0.0650	-1.45%
	US Soybeans	1,164.62	+3.62	+0.31%

	U.S. 10Y	4.612	-0.011	-0.24%
	U.S. 30Y	4.711	-0.013	-0.28%
	U.S. 5Y	4.656	-0.005	-0.11%
	U.S. 3M	5.415	+0.019	+0.36%
	US 10Y T-Note	107.92	+0.06	+0.06%
	Euro Bund	131.34	+0.14	+0.11%
	10-2 Yield Spread	-36.50	+0.22	+-0.60%

	Apple	165.84	+0.84	+0.51%
	Alphabet A	156.28	+2.19	+1.42%
	Tesla	142.05	-5.00	-3.40%
	Amazon.com	177.23	+2.60	+1.49%
	Netflix	554.60	-0.44	-0.08%
	Meta Platforms	481.73	+0.66	+0.14%
	Bank of America	37.73	+0.76	+2.06%

Recent Quotes

	Name	Price	Chg.	Chg. %
	CPRX	15.100	-0.030	-0.20%

	Name	Last	Chg. %	Vol.
	TSLA	142.05	-3.40%	106.25M
	NVDA	795.18	+4.35%	59.23M
	AMD	148.64	+1.36%	48.18M
	AAPL	165.84	+0.51%	47.92M
	MSFT	400.96	+0.46%	19.58M
	META	481.73	+0.14%	16.36M
	BRKa	617,284	+0.99%	18.07K

	Name	Last	Chg. %	Vol.
	PDD	124.14	+9.38%	13.15M
	F	12.88	+6.10%	86.08M
	UAL	53.94	+4.98%	16.36M
	NVDA	795.18	+4.35%	59.23M
	MDB	340.16	+3.88%	1.41M
	ENPH	110.51	+3.78%	3.54M
	DVA	132.52	+3.68%	660.11K

	Name	Last	Chg. %	Vol.
	CAH	102.83	-4.95%	5.28M
	VZ	38.60	-4.67%	49.99M
	NEM	37.46	-4.00%	13.83M
	TSLA	142.05	-3.40%	106.25M
	UNH	491.23	-1.98%	4.67M
	IP	34.76	-1.72%	7.29M
	LYV	88.45	-1.68%	2.31M